Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Mar 4;9(4):2281-2284.
doi: 10.1002/ccr3.4012. eCollection 2021 Apr.

Prenatal management of fetal goiter alternating between hypothyroidism and hyperthyroidism in a mother with Graves' disease

Affiliations
Case Reports

Prenatal management of fetal goiter alternating between hypothyroidism and hyperthyroidism in a mother with Graves' disease

Hortense Didier-Mathon et al. Clin Case Rep. .

Abstract

We present a rare documented case with consecutive hypo- and hyperthyroidism during fetal life. First, hypothyroidism was due to transplacental passage of antithyroid drugs. After the mother's thyroidectomy, fetal hyperthyroidism was due to transplacental passage of persistent anti-thyrotropin receptor antibodies. Fetal goiter disappeared after adjusting maternal treatment.

Keywords: endocrinology and metabolic disorders; fetal goiter; maternal Grave's disease; obstetrics and gynecology; prenatal management.

PubMed Disclaimer

Conflict of interest statement

None declared.

Figures

FIGURE 1
FIGURE 1
A, Thyroid peripheral hypervascularization in an axial ultrasound section at 22 weeks B, Thyroid central hypervascularization in an axial ultrasound section at 28 weeks and 6 days
FIGURE 2
FIGURE 2
A, Evolution of fetal thyroid diameter. B, Evolution of fetal thyroid circumference. C, Medication dosage of carbimazol (NMZ) and levothyroxine (L‐T4). FBS, fetal blood sample

Similar articles

References

    1. Subekti I, Pramono LA. Current diagnosis and management of graves’ disease. Acta Med Indones. 2018;50(2):177‐182. - PubMed
    1. Banigé M, Estellat C, Biran V, et al. Study of the factors leading to fetal and neonatal dysthyroidism in children of patients with Graves disease. J Endocr Soc. 2017;1(6):751‐761. - PMC - PubMed
    1. Hirsch D, Levy S, Nadler V, Kopel V, Shainberg B, Toledano Y. Pregnancy outcomes in women with severe hypothyroidism. Eur J Endocrinol. 2013;169(3):313‐320. - PubMed
    1. Kahaly GJ, Bartalena L, Hegedüs L, Leenhardt L, Poppe K, Pearce SH. 2018 European thyroid association guideline for the management of graves’ hyperthyroidism. Eur Thyroid J. 2018;7(4):167‐186. - PMC - PubMed
    1. Huel C, Guibourdenche J, Vuillard E, et al. Use of ultrasound to distinguish between fetal hyperthyroidism and hypothyroidism on discovery of a goiter. Ultrasound Obstet Gynecol. 2009;33(4):412‐420. - PubMed

Publication types

LinkOut - more resources